GEORGETOWN UNIVERSITY
Patent Owner
Stats
- 214 US PATENTS IN FORCE
- 31 US APPLICATIONS PENDING
- Mar 01, 2018 most recent publication
Details
- 214 Issued Patents
- 0 Issued in last 3 years
- 0 Published in last 3 years
- 8,747 Total Citation Count
- Jan 20, 1978 Earliest Filing
- 237 Expired/Abandoned/Withdrawn Patents
Patent Activity in the Last 10 Years
Technologies
Intl Class
Technology
Matters
Rank in Class
Top Patents (by citation)
| Upgrade to the Professional Level to View Top Patents for this Owner. Learn More |
Recent Publications
Publication #
Title
Filing Date
Pub Date
Intl Class
2018/0053,973 STRIPLINE DETECTOR FOR IN SITU BATTERY AND FUEL CELL NMRAug 21, 17Feb 22, 18[H01M, G01N, G01R]
2017/0351,742 Application Programming Interface and Hypergraph Transfer Protocol Supporting a Global Hypergraph Approach to Reducing Complexity For Accelerated Multi-Disciplinary Scientific DiscoveryJun 05, 17Dec 07, 17[G06N, G06F]
2017/0246,259 Compositions and Methods of Using Interleukin-4 Induced Gene 1 (IL-4I1)Sep 09, 15Aug 31, 17[A61K, C12Q, G01N]
Recent Patents
Patent #
Title
Filing Date
Issue Date
Intl Class
9849192 Targeting tumor cells with chemotherapeutic agents conjugated to matriptase antibodiesMar 18, 16Dec 26, 17[A61K, C07K]
9789160 Treatments for lowering glucose levels using FGF binding protein 3Sep 14, 15Oct 17, 17[A61K]
9746985 System and method for detecting, collecting, analyzing, and communicating event-related informationApr 20, 11Aug 29, 17[G06F]
Expired/Abandoned/Withdrawn Patents
Patent #
Title
Status
Filing Date
Issue/Pub Date
Intl Class
2017/0165,254 TREATING FLAVIVIRUS INFECTIONS WITH AMODIAQUINE AND DERIVATIVES THEREOFAbandonedFeb 05, 15Jun 15, 17[A61K]
2017/0000,746 METHODS FOR TREATING HEAT STRESS AND RELATED COMPOSITIONSAbandonedSep 14, 16Jan 05, 17[A61K]
2015/0311,556 PLATINUM ADLAYERED RUTHENIUM NANOPARTICLES, METHOD FOR PREPARING, AND USES THEREOFAbandonedJul 08, 15Oct 29, 15[H01M]
2015/0252,372 PREPARATION OF ANTIBODY OR AN ANTIBODY FRAGMENT TARGETED IMMUNOLIPOSOMES FOR SYSTEMIC ADMINISTRATION OF THERAPEUTIC OR DIAGNOSTIC AGENTS AND USES THEREOFAbandonedApr 24, 15Sep 10, 15[A61K, C12N, C07K]
2015/0196,530 Use of Artemisinin for Treating Tumors Induced by Oncogenic Viruses and for Treating Viral InfectionsAbandonedJan 26, 15Jul 16, 15[A61K]
2015/0086,648 METHODS FOR TREATING HEAT STRESS AND RELATED COMPOSITIONSAbandonedOct 07, 14Mar 26, 15[A61K]
2014/0341,965 Compositions and Methods Comprising Biodegradable Scaffolds and Retinal Pigment Epithelial CellsAbandonedMar 14, 14Nov 20, 14[A61K, C12N, A61L]
2014/0322,809 Use of a Rock Inhibitor to Sustain Primary Human Keratinocytes in a Proliferative StateAbandonedNov 20, 13Oct 30, 14[C12N]
2014/0294,845 ANTI-PLEIOTROPHIN ANTIBODIES AND METHODS OF USE THEREOFAbandonedFeb 03, 14Oct 02, 14[A61K, C07K]
2014/0287,409 Detection And Assessment Of Cancer Risk Using Telomere HealthAbandonedMar 14, 14Sep 25, 14[C12Q]
2014/0243,319 TREATMENTS TARGETING GAMMA-SYNUCLEIN EXPRESSION LEVELSAbandonedMar 16, 12Aug 28, 14[A61K, G01N]
2014/0178,296 TUMOR-TARGETED NANODELIVERY SYSTEMS TO IMPROVE EARLY MRI DETECTION OF CANCERAbandonedDec 06, 13Jun 26, 14[A61K]
2014/0134,564 ARCH BARS FOR USE IN MAXILLOFACIAL SURGERY AND ORTHODONTICSAbandonedJan 21, 14May 15, 14[A61C]
2014/0121,485 Electrochemical Transdermal Glucose Measurement System Including Microheaters and Process For FormingAbandonedApr 30, 12May 01, 14[C25D, A61B]
2014/0094,384 STROMAL ANTIGEN 2 (STAG2) COMPOSITIONS AND METHODSAbandonedNov 25, 13Apr 03, 14[C12Q, C12N, G01N, C07K]
2014/0066,384 NOVEL GENES AND PROTEINS THAT HOME TO DEVELOPING MICROVESSELSAbandonedApr 15, 13Mar 06, 14[C07K]
2014/0044,873 SINGLE-WALLED CARBON NANOTUBE (SWCNT) FABRICATION BY CONTROLLED CHEMICAL VAPOR DEPOSITION (CVD)AbandonedAug 10, 12Feb 13, 14[C23C, B82Y]
2013/0324,543 REVERSAL OF HIGH BREAST CANCER RISK IN MAMMALS EXPOSED TO ESTROGENIC CHEMICALS IN UTERO BY ADULT EXPOSURE TO HDAC AND DNMT INHIBITORSAbandonedApr 05, 13Dec 05, 13[C12Q]
Top Inventors for This Owner
| Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More |
We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.
